RA Capital Management Closes First Fund, at Over $300M
Summary
It provides seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation from inception through commercialization. The incubator currently has 19 programs in discovery and early development and works to advance them in a time- and cost-efficient manner. To date, two companies have been launched with drug candidates based on molecules initially discovered and developed in the incubator. The venture partner and executive-in-residence programs bring in experienced executives and entrepreneurs who help to build and lead new companies. The firm’s investment process is led by RA Capital’s Managing Director group, which includes Portfolio Managers Peter Kolchinsky and Raj Shah, Co-Heads of Venture Josh Resnick and Andrew Levin, and nine other professionals.